PD353 400 (Rezulin 400 mg)
Generic Name: troglitazone
Pill imprint PD353 400 has been identified as Rezulin 400 mg.
Rezulin is used in the treatment of diabetes, type 2 and belongs to the drug class thiazolidinediones. There is no proven risk in humans during pregnancy. Rezulin 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
More about Rezulin (troglitazone)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.